Affimed Stock Analysis

AFMD -  USA Stock  

USD 3.96  0.13  3.18%

The big decline in price over the last few months for Affimed NV could raise concerns from shareholders as the firm it trading at a share price of 3.96 on 767,138 in volume. The company directors and management failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Affimed NV or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.94. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Affimed NV partners.
Please continue to Trending Equities.

Affimed Stock Analysis 

The Affimed NV stock analysis report makes it easy to digest most publicly released information about Affimed NV and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Affimed Stock analysis module also helps to analyze the Affimed NV price relationship with some important fundamental indicators such as market cap and management efficiency.

Affimed Stock Analysis Notes

About 65.0% of the company shares are held by institutions such as insurance companies. The book value of Affimed NV was presently reported as 1.12. The company recorded a loss per share of 0.5. Affimed NV had not issued any dividends in recent years. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 153 people. For more info on Affimed NV please contact Adi Hoess at 49 6221 6743 60 or go to

Affimed NV Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Affimed NV's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Affimed NV or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Affimed NV generated a negative expected return over the last 90 days
Affimed NV has high historical volatility and very poor performance
The company reported the previous year's revenue of 40.85 M. Net Loss for the year was (49.31 M) with profit before overhead, payroll, taxes, and interest of 28.86 M.
Affimed NV currently holds about 198.74 M in cash with (43.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66.
Affimed NV has a poor financial position based on the latest SEC disclosures
Roughly 65.0% of the company shares are held by institutions such as insurance companies
Latest headline from Affimed Announces Completion of Enrollment in REDIRECT, the Registration-Directed Study of AFM13 in PTCL, and Provides Business Update - Yahoo Finance

Affimed NV Upcoming and Recent Events

Earnings reports are used by Affimed NV to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Affimed NV previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report21st of April 2022
Next Earnings Report7th of July 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End21st of April 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Affimed Largest EPS Surprises

Earnings surprises can significantly impact Affimed NV's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Affimed NV SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Affimed NV prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Affimed NV investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Affimed NV specific information freely available to individual and institutional investors to make a timely investment decision.

Affimed Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 510.34 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Affimed NV's market, we take the total number of its shares issued and multiply it by Affimed NV's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Affimed Profitablity

Affimed NV's profitability indicators refer to fundamental financial ratios that showcase Affimed NV's ability to generate income relative to its revenue or operating costs. If, let's say, Affimed NV is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Affimed NV's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Affimed NV's profitability requires more research than a typical breakdown of Affimed NV's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (120.7) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (123.89) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -1.24.
Last ReportedProjected for 2022
Return on Average Assets(0.33) (0.36) 
Return on Average Equity(0.67) (0.73) 
Return on Invested Capital 1.17  1.20 
Return on Sales(1.41) (1.52) 

Management Efficiency

The entity has return on total asset (ROA) of (19.27) % which means that it has lost $19.27 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (54.52) %, meaning that it created substantial loss on money invested by shareholders. Affimed NV management efficiency ratios could be used to measure how well affimed nv manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Invested Capital is expected to grow to 1.20, whereas Return on Average Assets are forecasted to decline to (0.36) . Affimed NV Current Assets are projected to increase significantly based on the last few years of reporting. The past year's Current Assets were at 173.42 Million. The current year Assets Non Current is expected to grow to about 30.9 M, whereas Return on Average Assets are forecasted to decline to (0.36) .
Last ReportedProjected for 2022
Book Value per Share 0.99  0.79 
Enterprise Value over EBIT(9.20) (9.93) 
Enterprise Value over EBITDA(9.65) (10.41) 
Price to Book Value 5.81  4.77 
Tangible Assets Book Value per Share 2.40  2.25 
Enterprise Value395.3 M426.5 M
Tangible Asset Value200.1 M215.9 M

Technical Drivers

As of the 25th of January, Affimed NV shows the mean deviation of 3.19, and Risk Adjusted Performance of (0.11). Affimed NV technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for nineteen technical drivers for Affimed NV, which can be compared to its rivals. Please confirm Affimed NV downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if Affimed NV is priced correctly, providing market reflects its regular price of 3.96 per share. Given that Affimed NV has jensen alpha of (0.54), we suggest you to validate Affimed NV's prevailing market performance to make sure the company can sustain itself at a future point.

Affimed NV Price Movement Analysis

The output start index for this execution was one with a total number of output elements of sixty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Affimed NV middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Affimed NV. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Affimed NV Technical and Predictive Indicators

Affimed NV Forecast Models

Affimed NV time-series forecasting models is one of many Affimed NV's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Affimed NV's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Affimed Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Affimed NV stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Affimed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Affimed NV. By using and applying Affimed Stock analysis, traders can create a robust methodology for identifying Affimed entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(1.36) (1.47) 
Gross Margin 0.90  0.89 
Profit Margin(1.68) (1.81) 
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 153 people.

Current Affimed Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Affimed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Affimed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
12.4Strong Buy5Odds
Affimed NV current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Affimed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Affimed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Affimed NV, talking to its executives and customers, or listening to Affimed conference calls.
Affimed Analyst Advice Details

Affimed Stock Analysis Indicators

Affimed NV stock analysis indicators help investors evaluate how Affimed NV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Affimed NV shares will generate the highest return on investment. By understating and applying Affimed NV stock analysis, traders can identify Affimed NV position entry and exit signals to maximize returns.
Quick Ratio3.05
Fifty Two Week Low4.2000
Revenue Growth-16.50%
Shares Short Prior Month3.72M
Average Daily Volume Last 10 Day1.2M
Average Daily Volume In Three Month1.88M
Shares Percent Shares Out2.41%
Gross Margins100.00%
Short Percent Of Float2.48%
Forward Price Earnings-7.22
Float Shares116.57M
Fifty Two Week High11.7400
Enterprise Value To Ebitda-6.82
Fifty Day Average5.8672
Two Hundred Day Average7.1404
Enterprise Value To Revenue8.34
Please continue to Trending Equities. Note that the Affimed NV information on this page should be used as a complementary analysis to other Affimed NV's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Affimed Stock analysis

When running Affimed NV price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Affimed NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine Affimed NV value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.